EGLN1 and kidney cancer: The formation of PHD2.Fe(III).2OG.HIFα complexes is also of potential interest in the context of kidney cancer where mutations to VHL (VHL1) gene lead to HIFα upregulation and predisposition to clear cell renal cell carcinoma (ccRCC)87.